PLP1 and myeloid sarcoma: For example, we have shown that patients with a combination of multiple sclerosis (MS) and psoriasis tend to have prominent involvement of the brainstem and cerebellum lesions and to carry HLA-DRB1*07 (3) and have elevated levels of T cell reactivity against the 184–210 region of myelin proteolipid protein (PLP) (unpublished data).